Details for New Drug Application (NDA): 021799
✉ Email this page to a colleague
NDA 021799 describes QUALAQUIN, which is a drug marketed by Sun Pharm Industries and is included in one NDA. Additional details are available on the QUALAQUIN profile page.
The generic ingredient in QUALAQUIN is quinine sulfate. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.
The generic ingredient in QUALAQUIN is quinine sulfate. There are twelve drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the quinine sulfate profile page.
Summary for 021799
| Tradename: | QUALAQUIN |
| Applicant: | Sun Pharm Industries |
| Ingredient: | quinine sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021799
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 324MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Aug 12, 2005 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
